Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLIS: Bupivacaine for Perineal Pain After Vaginal Delivery
NCT03672500Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Sep 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine in perineal pain (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Proportion of women with Numeric Rating Scale score <= 4 at 6 hours. Started Sep 2018; status: terminated.
02
Drugs
bupivacaine
03
Conditions
perineal pain
Beyond the preview
Go deeper on NCT03672500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672500.